Back to companies
Lyell Immunopharma, Inc.
LYELUSNASDAQPharmaceuticals & HealthcareLyell Immunopharma, Inc.
Revenue
$36,000
YoY -41.0%
Operating income
-$269.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API